Yu DS - Search Results

1

Ketamine-associated bladder dysfunction.

Tsai TH, Cha TL, Lin CM, Tsao CW, Tang SH, Chuang FP, Wu ST, Sun GH, Yu DS, Chang SY. Tsai TH, et al. Among authors: yu ds. Int J Urol. 2009 Oct;16(10):826-9. doi: 10.1111/j.1442-2042.2009.02361.x. Epub 2009 Jul 29. Int J Urol. 2009. PMID: 19659678

2

The expression of oncoproteins in transitional cell carcinoma: its correlation with pathological behavior, cell cycle and drug resistance.

Yu DS, Chang SY. Yu DS, et al. Urol Int. 2002;69(1):46-50. doi: 10.1159/000064360. Urol Int. 2002. PMID: 12119439

3

Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior.

Yu DS, Chen HI, Chang SY. Yu DS, et al. Urol Int. 2002;69(2):129-35. doi: 10.1159/000065562. Urol Int. 2002. PMID: 12187044

4

Remote recurrence of malignant pheochromocytoma 14 years after primary operation.

Tang SH, Chen A, Lee CT, Yu DS, Chang SY, Sun GH. Tang SH, et al. Among authors: yu ds. J Urol. 2003 Jan;169(1):269. doi: 10.1016/S0022-5347(05)64086-4. J Urol. 2003. PMID: 12478154 No abstract available.

5

Synergism of Fas-mediated apoptosis and tumor necrosis factor on adriamycin cytotoxicity to transitional cell carcinoma.

Yu DS, Hsieh DS, Chen HI, Chang SY. Yu DS, et al. Urol Int. 2003;70(3):161-6. doi: 10.1159/000068772. Urol Int. 2003. PMID: 12660450

6

The expression of cyclooxygenase in transitional cell carcinoma cell lines: its correlation with tumor differentiation, invasiveness and prostanoids production.

Yu DS, Chen HI, Chang SY. Yu DS, et al. Eur Urol. 2003 Oct;44(4):491-4. doi: 10.1016/s0302-2838(03)00311-7. Eur Urol. 2003. PMID: 14499687

7

Modulation of prostate carcinoma cell growth and apoptosis by chromogranin A.

Yu DS, Hsieh DS, Chang SY. Yu DS, et al. J Urol. 2003 Nov;170(5):2031-5. doi: 10.1097/01.ju.0000091807.02246.f3. J Urol. 2003. PMID: 14532847

8

Immunotherapy for bladder cancer using recombinant bacillus Calmette-Guerin DNA vaccines and interleukin-12 DNA vaccine.

Lee CF, Chang SY, Hsieh DS, Yu DS. Lee CF, et al. Among authors: yu ds. J Urol. 2004 Mar;171(3):1343-7. doi: 10.1097/01.ju.0000103924.93206.93. J Urol. 2004. PMID: 14767345

9

Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapy.

Lee CF, Chang SY, Hsieh DS, Yu DS. Lee CF, et al. Among authors: yu ds. Cancer Gene Ther. 2004 Mar;11(3):194-207. doi: 10.1038/sj.cgt.7700658. Cancer Gene Ther. 2004. PMID: 14973549

10

Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.

Yu DS, Lee CF, Hsieh DS, Chang SY. Yu DS, et al. Urology. 2004 Mar;63(3):596-601. doi: 10.1016/j.urology.2003.09.039. Urology. 2004. PMID: 15028475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

655 results

Search Page

Filters